Weight loss drugs such as Ozempic, Wegovy and Mounjaro seem to directly impact metabolism, not just appetite, according to a new study. It was previously thought these drugs—collectively called glucagon-like peptide 1 (GLP-1) analogs—worked by making people feel fuller so they eat less. But the results of a recent clinical trial suggest it’s not as …
New Delhi: A new study led by the Alfred Wegener Institute and published in Science journal on 4 July has found a plausible reason for why Antarctica’s ice sheets, particularly in West Antarctica, are melting more rapidly than previously believed. Sediment samples from drill cores and climate and ice-sheet modeling indicate that permanent ice formation began in East …
The increasing popularity of weight loss drugs like Ozempic and Wegovy has given rise to a new term- “Ozempic Babies.” While the most common side effects of the drug include nausea, digestive issues, and severe diarrhoea, a lesser-known side effect has now come to light. Many women have come forward with stories of their unexpected …
What happens if you have to go off weight-loss drugs? What happens if you have to go off weight-loss drugs? It’s a growing concern for the millions of Americans taking medications including Wegovy, Zepbound or Ozempic. Employer-health plans are tightening requirements or dropping coverage. And manufacturers’ discount coupons for initial supplies of medication expire, leaving …
Semaglutide, a diabetes and obesity treatment that has grown in popularity in recent years, can be associated with a lower risk of suicidal ideation compared to other medications, according to a recent analysis. The study, funded by the National Institutes of Health (NIH), found that semaglutide was associated with a 49 to 73 percent lower …
Researchers are studying prominent weight-loss medicines like Ozempic and Wegovy to find their utility in the treatment of kidney disease, heart failure, neurological disorders, and other ailments. Semaglutide, the generic name of Ozempic was one of the most talked-about medicines of 2023 for weight loss. After creating buzz in the weight-loss segment, the medicine may …
London: Novo Nordisk’s Ozempic (semaglutide) took the weight loss sector by storm in 2023, propelled by strong efficacy and safety data coupled with social media buzz and celebrity endorsements that elevated the drug to mainstream prominence. However, a potential challenger has emerged in the form of Eli Lilly’s Mounjaro (tirzepatide), which secured FDA approval for …